Devin Whittemore Smith insider trades

Open-market stock purchases and sales by Devin Whittemore Smith, General Counsel at IO Biotech, Inc, from SEC Form 4 filings since Aug 1, 2018.

Recent trades

No open-market trades in the last 12 months.

Companies traded

IOBT IO Biotech, Inc: 1 buy, last Apr 2, 2025
YMTX Yumanity Therapeutics, Inc: 2 sales, last Dec 2, 2022
NERV Minerva Neurosciences, Inc: other filings, last Oct 13, 2020

Get free alerts when Devin Whittemore Smith files a new trade →